HR 1349 · in committee · major
Women’s Protection in Telehealth Act
- reproductive rights
- healthcare
What this bill does
- Restricts abortion-inducing drug providers from Medicare unless they are physicians meeting specific in-person visit requirements.
- Affects patients seeking medication abortion and healthcare providers offering telehealth abortion services.
- Takes effect by limiting Medicare participation for providers who don't comply with physical examination and follow-up visit requirements.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would requiring in-person visits for medication abortion through Medicare affect patients in rural or underserved areas with limited access to providers?
- 02
What evidence supports the claim that physical examinations are medically necessary for medication abortion compared to current telehealth protocols?
- 03
Which healthcare providers and patients would be most impacted if Medicare-participating providers stop offering telehealth abortion services?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-FL-17
W. Gregory Steube
Citizen cosponsors
0
In Congress
7/ 435
House Reps cosponsoring
Introduced 2025-02-13
Joining the bill
Legislative timeline
2025-02-13 · house · IntroReferral
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-13 · house · IntroReferral
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-13 · IntroReferral
Introduced in House
2025-02-13 · IntroReferral
Introduced in House

Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.